Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that is building a platform for interpreting human… read more
Turbine, a company that is building the world’s first predictive simulation of patient biology, and Harmonic Discovery (Harmonic), a therapeutics company building an integrated computational… read more
Turbine, the leading biological simulation company building a platform for interpreting human biology in silico, is proud to announce that it is an initial member… read more
Turbine, a leading biological simulation company building a platform for interpreting human biology in silico, today announced it has entered into a collaboration with AstraZeneca… read more
Turbine, a computational biology company that deploys empirically validated in silico cell simulations to guide biopharma R&D, today announced that it has entered into a… read more
Turbine, a digital biology company that deploys empirically validated in silico cell simulations to guide biopharma R&D, today announced the appointment of Bob Silverman as… read more